Insulin Glulisine Suppliers & Bulk Manufacturers
Available Forms: injection (prefilled syringe)
Available Strengths: 100 IU/mL
Reference Brands: Apidra (USA/EU)
Category:
Diabetes
Insulin Glulisine is a rapid-acting insulin analog used to manage blood glucose levels in patients with diabetes mellitus. It works by replacing or supplementing endogenous insulin, facilitating glucose uptake into cells, and reducing blood sugar levels after meals. It is administered via subcutaneous injection and may also be given intravenously in hospital settings for rapid glycemic control.
Insulin glulisine is available in injection (prefilled syringe)
and strengths such as 100 IU/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Insulin glulisine is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Insulin glulisine can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing